Cargando…

Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas

SIMPLE SUMMARY: Intratumor heterogeneity (ITH) is a constant event in malignant tumors and the cause of most therapeutic failures in modern oncology. Since clear cell renal cell carcinoma (CCRCC) is a paradigm of ITH, an appropriate tumor sampling is mandatory to unveil its histological and genomic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manini, Claudia, López-Fernández, Estíbaliz, López, José I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322795/ https://www.ncbi.nlm.nih.gov/pubmed/35884442 http://dx.doi.org/10.3390/cancers14143381

Ejemplares similares

Pathology and the evolutionary dynamics of clear cell renal cell carcinoma
por: Manini, Claudia, et al.
Publicado: (2022)

Updating Clear Cell Renal Cell Carcinoma (a Tribute to Prof. Ondrej Hes)
por: Manini, Claudia, et al.
Publicado: (2022)

The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling
por: López-Fernández, Estíbaliz, et al.
Publicado: (2018)

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments
por: Angulo, Javier C., et al.
Publicado: (2021)

The Labyrinth of Renal Cell Carcinoma
por: Manini, Claudia, et al.
Publicado: (2020)

Tumor-to-Tumor Metastases Involving Clear Cell Renal Cell Carcinomas: A Diagnostic Challenge for Pathologists Needing Clinical Correlation †
por: Manini, Claudia, et al.
Publicado: (2023)

Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
por: Larrinaga, Gorka, et al.
Publicado: (2021)

HIF1A predicts the efficacy of anti-PD-1 therapy in advanced clear cell renal cell carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022)

Snail heterogeneity in clear cell renal cell carcinoma
por: Zaldumbide, Laura, et al.
Publicado: (2016)

Metastasis, an Example of Evolvability
por: Laruelle, Annick, et al.
Publicado: (2021)

Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)

Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
por: Sarkis, J., et al.
Publicado: (2021)

Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC)
por: Guarch, Rosa, et al.
Publicado: (2016)

A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma
por: Lopez, José I., et al.
Publicado: (2016)

Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic
por: López-Fernández, Estibaliz, et al.
Publicado: (2022)

Advances in Urological Cancer in 2022, from Basic Approaches to Clinical Management
por: Manini, Claudia, et al.
Publicado: (2023)

Benign Mesothelial Proliferations of the Tunica Vaginalis Testis
por: Manini, Claudia, et al.
Publicado: (2023)

The renal clear cell carcinoma immune landscape
por: Saad, Omar A., et al.
Publicado: (2022)

The Gut Microbiome and Metastatic Renal Cell Carcinoma
por: Meza, Luis, et al.
Publicado: (2023)

Thyroid metastasis as initial presentation of clear cell renal carcinoma
por: Ramírez-Plaza, César Pablo, et al.
Publicado: (2015)

The role of immunotherapy in non-clear cell renal cell carcinoma
por: Climent, Carla, et al.
Publicado: (2023)

Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma
por: Li, Jin, et al.
Publicado: (2019)

Emerging Targets in Clear Cell Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
por: Palomero, Luis, et al.
Publicado: (2020)

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma
por: Cuvillier, Olivier
Publicado: (2017)

Towards AI-powered personalization in MOOC learning
por: Yu, Han, et al.
Publicado: (2017)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Monjaras-Avila, Cesar U., et al.
Publicado: (2023)

Clear Cell Papillary Renal Cell Carcinoma: A Potential Mimic of Conventional Clear Cell Renal Carcinoma on Core Biopsy
por: Liddell, Heath, et al.
Publicado: (2015)

Toward Personalized Control of Human Gut Bacterial Communities
por: David, Lawrence A.
Publicado: (2018)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma
por: Miles, James, et al.
Publicado: (2017)

Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022)

Paraneoplastic Eosinophilia in Clear Cell Renal Cell Carcinoma
por: Zhou, Wei-Wei, et al.
Publicado: (2015)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)

An Immune Atlas of Clear Cell Renal Cell Carcinoma
por: Chevrier, Stéphane, et al.
Publicado: (2017)

Immune classification of clear cell renal cell carcinoma
por: Su, Sumeyye, et al.
Publicado: (2021)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3lfb1s1nde2ff5bn3a8v6v06hr